Madrigal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	227.03	198.69	100.02	99.92	331.55	36.27
Short-Term Investments	585.74	784.87	826.23	534.22	27.23	234.08
Cash & Short-Term Investments	812.77	983.56	926.25	634.13	358.77	270.35
Cash Growth	-3.59%	6.19%	46.07%	76.75%	32.71%	-4.86%
Accounts Receivable	187.36	134.48	53.82	-	-	-
Inventory	112.07	74.84	34.07	-	-	-
Other Current Assets	70.11	52.89	18.79	3.15	2.6	1.34
Total Current Assets	1,182	1,246	1,033	637.28	361.37	271.68
Net Property, Plant & Equipment	14.24	6.44	4.59	3.27	1.2	1.65
Other Intangible Assets	7.28	7.38	4.73	-	-	-
Other Long-Term Assets	23.5	-	-	-	-	-
Total Assets	1,227	1,260	1,042	640.55	362.57	273.33
Accounts Payable	60.8	48.88	43.6	28.04	23.83	21.38
Accrued Expenses	275.76	260.39	124.7	89.98	91.46	55.05
Current Portion of Leases	1.7	1.02	0.98	0.53	0.6	0.41
Total Current Liabilities	338.26	310.29	169.28	118.55	115.89	76.84
Long-Term Debt	340.33	339.88	117.57	115.48	49.29	-
Long-Term Leases	5.28	6.73	1.02	1.19	-	0.39
Total Long-Term Liabilities	345.61	346.61	118.59	116.67	49.29	0.39
Total Liabilities	683.87	656.9	287.86	235.21	165.18	77.23
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	2,727	2,692	2,556	1,741	1,160	863.5
Accumulated Other Comprehensive Income	1.08	0.87	0.47	0.47	-0.03	-0.08
Retained Earnings	-2,185	-2,090	-1,802	-1,336	-962.66	-667.31
Shareholders' Equity	543.45	602.69	754.38	405.33	197.39	196.11
Total Liabilities & Equity	1,227	1,260	1,042	640.55	362.57	273.33
Total Debt	347.31	347.63	119.57	117.19	49.89	0.8
Net Cash (Debt)	465.46	635.93	806.68	516.94	308.88	269.55
Net Cash Growth	-26.81%	-21.17%	56.05%	67.36%	14.59%	-4.88%
Net Cash Per Share	19.28	28.35	37.92	27.66	18.02	16.30
Book Value	543.45	602.69	754.38	405.33	197.39	196.11
Book Value Per Share	22.51	26.86	35.46	21.69	11.52	11.86
Tangible Book Value	536.17	595.31	749.65	405.33	197.39	196.11
Tangible Book Value Per Share	22.21	26.54	35.24	21.69	11.52	11.86

SEC Filings: 10-K · 10-Q